For patients and pharmacists in financially stricken Greece, even finding Aspirin has turned into a headache.
Mina Mavrou, who runs a pharmacy in a
middle-class Athens suburb, spends hours each day pleading with
drugmakers, wholesalers and colleagues to hunt down medicines for
clients. Life-saving drugs such as Sanofi’s blood-thinner Clexane and
GlaxoSmithKline Plc’s asthma inhaler Flixotide often appear as lines of
crimson data on pharmacists’ computer screens, meaning the products
aren’t in stock or that pharmacists can’t order as many units as they
need.
businessweek
